A Tail Fiber Protein and a Receptor-Binding Protein Mediate ICP2 Bacteriophage Interactions with Vibrio Cholerae OmpU
Overview
Affiliations
ICP2 is a virulent bacteriophage (phage) that preys on Vibrio cholerae. ICP2 was first isolated from cholera patient stool samples. Some of these stools also contained ICP2-resistant isogenic V. cholerae strains harboring missense mutations in the trimeric outer membrane porin protein OmpU, identifying it as the ICP2 receptor. In this study, we identify the ICP2 proteins that mediate interactions with OmpU by selecting for ICP2 host range mutants within infant rabbits infected with a mixture of wild-type and OmpU mutant strains. ICP2 host range mutants that can now infect OmpU mutant strains have missense mutations in the putative tail fiber gene and the putative adhesin gene . Using site-specific mutagenesis, we show that single or double mutations in are sufficient to generate the host range mutant phenotype. However, at least one additional mutation in is required for robust plaque formation on specific OmpU mutants. Mutations in alone were insufficient to produce a host range mutant phenotype. All ICP2 host range mutants retained the ability to form plaques on wild-type V. cholerae cells. The strength of binding of host range mutants to V. cholerae correlated with plaque morphology, indicating that the selected mutations in and restore molecular interactions with the receptor. We propose that ICP2 host range mutants evolve by a two-step process. First, mutations are selected for their broad host range, albeit accompanied by low-level phage adsorption. Subsequent selection occurs for mutations that further increase productive binding to specific OmpU alleles, allowing for near-wild-type efficiencies of adsorption and subsequent phage multiplication. Concern over multidrug-resistant bacterial pathogens, including Vibrio cholerae, has led to renewed interest in phage biology and the potential for phage therapy. ICP2 is a genetically unique virulent phage isolated from cholera patient stool samples. It is also one of three phages in a prophylactic cocktail that have been shown to be effective in animal models of infection and the only one of the three that requires a protein receptor (OmpU). This study identifies an ICP2 tail fiber and a receptor binding protein and examines how ICP2 responds to the selective pressures of phage-resistant OmpU mutants. We found that this particular coevolutionary arms race presents fitness costs to both ICP2 and V. cholerae.
Engineering Phages to Fight Multidrug-Resistant Bacteria.
Peng H, Chen I, Qimron U Chem Rev. 2024; 125(2):933-971.
PMID: 39680919 PMC: 11758799. DOI: 10.1021/acs.chemrev.4c00681.
A anti-phage system depletes nicotinamide adenine dinucleotide to restrict virulent bacteriophages.
Woldetsadik Y, Lazinski D, Camilli A mBio. 2024; 15(11):e0245724.
PMID: 39377576 PMC: 11559045. DOI: 10.1128/mbio.02457-24.
Maciel-Guerra A, Babaarslan K, Baker M, Rahman A, Hossain M, Sadique A Nat Commun. 2024; 15(1):8231.
PMID: 39313510 PMC: 11420230. DOI: 10.1038/s41467-024-52238-0.
Chen N, Li Y, Liang X, Qin K, Zhang Y, Wang J Biofilm. 2024; 8:100216.
PMID: 39184814 PMC: 11341940. DOI: 10.1016/j.bioflm.2024.100216.
A Anti-Phage System Depletes Nicotinamide Adenine Dinucleotide to Restrict Virulent Bacteriophages.
Woldetsadik Y, Lazinski D, Camilli A bioRxiv. 2024; .
PMID: 38948830 PMC: 11212891. DOI: 10.1101/2024.06.17.599363.